BRD9 and posterior cortical atrophy: Taken together, the data presented here identify glycogen degradation not only as a hallmark of PCa metabolism but also as a potent, disease-driving oncogenic pathway activated by BRD9 to benefit PCa survival and finally lead to an androgen-deprivation or castration-resistant phenotype.